Published in Eur Heart J on March 01, 1991
Triage of Reduced Exercise Tolerance in Frail Elderly (TREE) | NCT01148719
Open access echocardiography in management of heart failure in the community. BMJ (1995) 7.83
Epidemiology and risk profile of heart failure. Nat Rev Cardiol (2010) 4.88
Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J (1994) 4.40
Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ (2003) 4.24
Clinical epidemiology of heart failure. Heart (2007) 4.11
Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ (1996) 3.59
Prevalence of heart failure in three general practices in north west London. Br J Gen Pract (1992) 2.88
Cluster randomised controlled trial of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care. Br J Gen Pract (2002) 2.58
Easy access echocardiography for the general practitioner: results from the Parkstad area in the Netherlands. Int J Cardiovasc Imaging (2005) 2.20
Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature. Heart (1996) 1.79
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol (2007) 1.70
Role of echocardiography in the evaluation of syncope: a prospective study. Heart (2002) 1.51
Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol (1997) 1.48
Barriers to optimum management of heart failure by general practitioners. Br J Gen Pract (1999) 1.42
Automatic identification of heart failure diagnostic criteria, using text analysis of clinical notes from electronic health records. Int J Med Inform (2013) 1.39
Central role of echocardiography in the diagnosis and assessment of heart failure. British Society of Echocardiography. Heart (1998) 1.38
Barriers to accurate diagnosis and effective management of heart failure have not changed in the past 10 years: a qualitative study and national survey. BMJ Open (2014) 1.36
Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ (2000) 1.35
Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. BMJ (1998) 1.32
The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract (2006) 1.22
Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart (1996) 1.21
Diagnosis of patients with chronic heart failure in primary care: usefulness of history, examination, and investigations. Br J Gen Pract (2000) 1.21
Current clinical applications of spectral tissue Doppler echocardiography (E/E' ratio) as a noninvasive surrogate for left ventricular diastolic pressures in the diagnosis of heart failure with preserved left ventricular systolic function. Cardiovasc Ultrasound (2007) 1.16
Prehospital emergency ultrasound: a review of current clinical applications, challenges, and future implications. Emerg Med Int (2013) 1.14
Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther (2005) 1.13
Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. Heart (2002) 1.12
Why, when, and how to assess pulmonary congestion in heart failure: pathophysiological, clinical, and methodological implications. Heart Fail Rev (2010) 1.10
Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk. Heart (2001) 1.07
Novel biomarkers in chronic heart failure. Nat Rev Cardiol (2012) 1.06
Determinants of locomotor disability in people aged 55 years and over: the Rotterdam Study. Eur J Epidemiol (2001) 1.04
Diagnosis of heart failure in primary care. Heart Fail Rev (2006) 1.03
Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients? Br J Gen Pract (2000) 1.01
Prognostic implications of qualitative assessment of left ventricular function compared to simple routine quantitative echocardiography. Heart (1997) 0.96
Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations. Heart (2004) 0.95
General practitioners' reasoning when considering the diagnosis heart failure: a think-aloud study. BMC Fam Pract (2005) 0.94
Evaluation of an open access echocardiography service in the Netherlands: a mixed methods study of indications, outcomes, patient management and trends. BMC Health Serv Res (2010) 0.93
The REFER (REFer for EchocaRdiogram) protocol: a prospective validation of a clinical decision rule, NT-proBNP, or their combination, in the diagnosis of heart failure in primary care. Rationale and design. BMC Cardiovasc Disord (2012) 0.93
Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial. BMC Fam Pract (2011) 0.91
Screening for left ventricular dysfunction in the community: role of hand held echocardiography and brain natriuretic peptides. Heart (2003) 0.90
The Dutch experience of open access echocardiography. Neth Heart J (2007) 0.89
Diagnostic triage and the role of natriuretic peptide testing and echocardiography for suspected heart failure: an appropriateness ratings evaluation by UK GPs. Br J Gen Pract (2011) 0.88
Identification of Sonographic B-lines with Linear Transducer Predicts Elevated B-Type Natriuretic Peptide Level. West J Emerg Med (2011) 0.88
Congestive heart failure arising from diastolic dysfunction in the presence of normal left-ventricular systolic function. Tex Heart Inst J (1999) 0.88
Heart failure diagnosis in primary health care: clinical characteristics of problematic patients. A clinical judgement analysis study. BMC Fam Pract (2003) 0.88
Treatment of heart failure in Dutch general practice. BMC Fam Pract (2006) 0.87
Open access echocardiography is feasible in the Netherlands. Neth Heart J (2006) 0.86
Angiography and the aetiology of heart failure. Postgrad Med J (1995) 0.85
Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2). BMC Public Health (2009) 0.83
Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF. Clin Res Cardiol (2014) 0.82
Sociodemographic factors and depressive symptoms in hospitalized patients with heart failure. Exp Clin Cardiol (2010) 0.82
Noninvasive assessment of acute dyspnea in the ED. Chest (2013) 0.81
Modern management of hypertension and heart failure: evidence and practice. Heart (2000) 0.80
Direct access echocardiography. Int J Cardiovasc Imaging (2006) 0.80
The prevalence, aetiology and management of heart failure. Br J Gen Pract (1996) 0.80
The use of angiotensin-converting enzyme inhibitors and other drugs with cardiovascular effects by non-demented and demented elderly with a clinical diagnosis of heart failure. A population-based study of the very old. Eur J Clin Pharmacol (2006) 0.79
Unmet need for diagnosis of heart failure: the view from primary care. Heart (2002) 0.79
The scale of heart failure: diagnosis and management issues for primary care. Heart (1999) 0.78
Novel strategies for the detection of systolic and diastolic heart failure. Curr Cardiol Rev (2009) 0.77
Contemporary management of heart failure in clinical practice. Heart (2002) 0.77
Diagnostic value of patterns of symptoms and signs of heart failure: application of latent class analysis with concomitant variables in a cross-sectional study. BMJ Open (2012) 0.77
Clinical burden and health service challenges of chronic heart failure. Br J Gen Pract (2010) 0.77
[Differential diagnosis of dyspnea - significance of clinic aspects, imaging and biomarkers for the diagnosis of heart failure]. Clin Res Cardiol (2006) 0.75
Heart detection and diagnosis based on ECG and EPCG relationships. Med Devices (Auckl) (2011) 0.75
Survival differences between heart failure in general practices and in hospitals. Heart (2003) 0.75
The Performance of Short-Term Heart Rate Variability in the Detection of Congestive Heart Failure. Biomed Res Int (2016) 0.75
Towards a blood test for heart failure: the potential use of circulating natriuretic peptides. Br J Clin Pharmacol (2000) 0.75
Diagnostic performance of multi-organ ultrasound with pocket-sized device in the management of acute dyspnea. Cardiovasc Ultrasound (2017) 0.75
Diagnosis of heart failure. Heart (1998) 0.75
The validity of the common symptoms and signs for the clinical diagnosis of heart failure (HF) in patients in whom a previously unrecognized heart failure was suspected. Eur Heart J (1991) 0.75
Triage of frail elderly with reduced exercise tolerance in primary care (TREE). A clustered randomized diagnostic study. BMC Public Health (2012) 0.75
Clinical case studies in heart failure management. Br J Clin Pharmacol (1999) 0.75
Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial. BMC Cardiovasc Disord (2014) 0.75
The management of patients with heart failure in a Slovenian community hospital: what has changed between 1997 and 2000? Wien Klin Wochenschr (2003) 0.75
Cardiopulmonary assessment: is improvement needed? World J Surg (2005) 0.75
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet (2001) 10.29
Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia (1992) 5.25
High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care (1998) 3.94
Smoking and risk of rheumatoid arthritis. J Rheumatol (1993) 3.63
Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ (1996) 3.56
Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther (2007) 3.53
Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis (1998) 3.50
The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med (2000) 3.10
Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A (1999) 3.07
The homeostasis model in the San Antonio Heart Study. Diabetes Care (1997) 2.92
Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev (1987) 2.88
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care (1998) 2.70
NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes (1994) 2.67
Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology (1995) 2.44
Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia (1993) 2.41
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care (1996) 2.35
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S) Circulation (1997) 2.34
Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J (2002) 2.31
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med (2000) 2.27
Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia (1998) 2.25
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study. BMJ (1998) 2.16
Food consumption and the incidence of type II diabetes mellitus. Eur J Clin Nutr (2005) 2.14
Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes (1995) 2.09
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail (1997) 2.08
Determinants of weight gain and overweight in adult Finns. Eur J Clin Nutr (1991) 2.04
Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men. Am J Hypertens (1998) 2.02
Non-cardiovascular disease mortality and diabetes mellitus. Lancet (1997) 2.01
Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation (2007) 1.98
Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation (1998) 1.98
Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke (1996) 1.97
Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy. Arterioscler Thromb Vasc Biol (1999) 1.95
Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation (1993) 1.90
A precision measurement of the mass of the top quark. Nature (2004) 1.87
Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol (1994) 1.82
Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J (1996) 1.82
Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens (1998) 1.80
Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation (2000) 1.79
Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care (1996) 1.78
Screening of family members of patients with premature coronary heart disease; results from the EUROASPIRE II family survey. Eur Heart J (2003) 1.77
Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis (2000) 1.74
Recessive inheritance of adult-type lactose malabsorption. Lancet (1973) 1.69
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia (2004) 1.67
Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut (2008) 1.64
Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation (1999) 1.64
Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes (1997) 1.64
Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol (2000) 1.62
Hyperostosis of the spine in an adult population. Its relation to hyperglycaemia and obesity. Ann Rheum Dis (1971) 1.61
The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand Suppl (1983) 1.59
Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study. J Epidemiol Community Health (2001) 1.57
Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med (1997) 1.55
Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness. Eur J Clin Invest (2001) 1.54
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia (2005) 1.52
Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl (1985) 1.52
Glucose tolerance and coronary heart disease: Helsinki policemen study. J Chronic Dis (1979) 1.52
Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease? Arch Intern Med (2001) 1.50
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl (2004) 1.50
Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men. J Clin Endocrinol Metab (1996) 1.49
Leptin concentrations, sex hormones, and cortisol in nondiabetic men. J Clin Endocrinol Metab (1997) 1.49
Diagnostic features of acute myocardial infarction--changes over time from 1983 to 1990: results from the FINMONICA AMI Register Study. J Intern Med (1995) 1.49
Oxidised LDL and progression of atherosclerosis. Lancet (1992) 1.49
Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis (2001) 1.47
Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia (2004) 1.46
Prevalence of left ventricular hypertrophy in Finnish primary health care hypertensive patients. J Hum Hypertens (2001) 1.46
Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease. Diabetologia (1988) 1.46
Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland. Eur Heart J (1997) 1.46
Differentiation of kidney mesenchyme in an experimental model system. Adv Morphog (1968) 1.44
Risk factors for injurious falls leading to hospitalization or death in a cohort of 19,500 adults. Am J Epidemiol (1993) 1.43
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care (1999) 1.43
Validity of hospital discharge data in a prospective epidemiological study on stroke and myocardial infarction. Acta Med Scand (1984) 1.43
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol (2000) 1.43
Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S) Eur Heart J (1998) 1.42
Gender differences in recurrent coronary events; the FINMONICA MI register. Eur Heart J (2001) 1.41
Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment. Eur Heart J (2001) 1.41
Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men. J Intern Med (2011) 1.40
Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol (1988) 1.38
Coronary heart disease case fatality in four countries. A community study. The Acute Myocardial Infarction Register Teams of Auckland, Augsburg, Bremen, FINMONICA, Newcastle, and Perth. Circulation (1993) 1.37
Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology (1985) 1.37
The epidemiology of insulin-dependent diabetes mellitus (IDDM) in Finland and in northern Europe. Diabetes Care (1985) 1.36
Metabolic precursors of hypertension. The San Antonio Heart Study. Arch Intern Med (1996) 1.36
The validity of hospital discharge register data on coronary heart disease in Finland. Eur J Epidemiol (1997) 1.36
Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med (2009) 1.35
Prevalence and ten-year (1970-1979) incidence of insulin-dependent diabetes mellitus in children and adolescents in Finland. Acta Paediatr Scand (1982) 1.34
Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl (1982) 1.34
Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). Am J Cardiol (1998) 1.32
Body iron stores and risk of cancer. Int J Cancer (1994) 1.31